Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ' Calquence shows PFS benefit in CLL patients

pharmatimesJune 18, 2019

Tag: AstraZeneca , PFS , CLL patients

PharmaSources Customer Service